Home › Funds › CRAWFORD INVESTMENT COUNSEL INC › DGX
CRAWFORD INVESTMENT COUNSEL INC position in DGX
QUEST DIAGNOSTICS INC · Health Care
CRAWFORD INVESTMENT COUNSEL INC reported holding 447,976 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$104.4M, representing 1.75% of its reported portfolio and ranking #15 among its reported holdings. CRAWFORD INVESTMENT COUNSEL INC has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How CRAWFORD INVESTMENT COUNSEL INC's DGX position evolved
CRAWFORD INVESTMENT COUNSEL INC first disclosed a stake in DGX in Q1 2024 at 417,362 shares (US$55.6M). The position peaked in Q3 2026 at 447,976 shares, worth US$104.4M. Across 11 filings, CRAWFORD INVESTMENT COUNSEL INC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 447,976 shares valued at US$104.4M — a reduction of -12,105 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 417.36K | $55.56M | New |
| Q2 2024 | 501.35K | $68.62M | Add |
| Q3 2024 | 507.56K | $78.80M | Add |
| Q4 2024 | 513.96K | $77.54M | Add |
| Q1 2025 | 499.18K | $84.46M | Reduce |
| Q2 2025 | 484.96K | $87.11M | Reduce |
| Q3 2025 | 494.43K | $94.23M | Add |
| Q4 2025 | 496.50K | $86.16M | Hold |
| Q1 2026 | 486.43K | $95.33M | Reduce |
| Q2 2026 | 460.08K | $97.51M | Reduce |
| Q3 2026 | 447.98K | $104.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 26 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.64M sh · $1.08B · Q3 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.93M sh · $449.89M · Q3 2026
- DAVIS SELECTED ADVISERS 1.33M sh · $308.97M · Q3 2026
- M&G Plc 770.10K sh · $179.43M · Q3 2026
More on CRAWFORD INVESTMENT COUNSEL INC
FAQ
How long has CRAWFORD INVESTMENT COUNSEL INC held DGX?
CRAWFORD INVESTMENT COUNSEL INC has disclosed DGX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is CRAWFORD INVESTMENT COUNSEL INC's current position in DGX?
As of Q3 2026, CRAWFORD INVESTMENT COUNSEL INC holds 447.98K shares of DGX (QUEST DIAGNOSTICS INC), valued at $104.41M, representing 1.75% of its reported portfolio and ranking #15.
Has CRAWFORD INVESTMENT COUNSEL INC been buying or selling DGX?
In the latest 13F filing (Q3 2026), CRAWFORD INVESTMENT COUNSEL INC reduced its position in DGX. The position peaked in Q3 2026 at 447.98K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.